Skip to content

Pheochromocytoma Paraganglioma Syndrome 7 C5193116

Published: July 22, 2026Updated: August 25, 2026

An inherited disorder increasing risk for neuroendocrine tumors. Patients need ongoing monitoring and coordinated care involving surgery and hormonal management.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
E34.9
ICD-11
5A00.0
Body system
endocrine
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(endocrine)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Endocrine management

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Surgical tumor resection

Complete surgical removal of pheochromocytoma or paraganglioma tumors is the primary curative treatment approach. Preoperative alpha-blockade is essential to control blood pressure and prevent hypertensive crisis during surgery. Laparoscopic techniques are preferred when anatomically feasible.

surgical
3

Alpha-blockade therapy

Alpha-adrenergic blockers such as phenoxybenzamine are initiated 10-14 days before surgery to control hypertension and prevent catecholamine surge complications. Beta-blockers may be added afterward for tachycardia control.

medication

Additional treatment options

Long-term surveillance program

Regular biochemical testing (plasma metanephrines, urinary catecholamines) and imaging studies are essential for detecting tumor recurrence or metachronous lesions. Surveillance protocols are tailored based on genetic mutation status and tumor characteristics.

monitoring

Genetic counseling services

Comprehensive genetic counseling is recommended for patients and family members due to the hereditary nature of this syndrome. Counseling addresses inheritance patterns, risk assessment, and implications for family planning.

psychological

Emergency preparedness planning

Patients are educated on recognizing signs of catecholamine crisis and maintaining emergency medical information. Avoidance of triggers such as certain medications, physical stress, and extreme temperatures is emphasized.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Pheochromocytoma Paraganglioma Syndrome 7 C5193116?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2014.

guideline2014
2

Favier J, Amar L, Buffet A. Molecular Genetics of Pheochromocytoma and Paraganglioma Syndromes. Ann Endocrinol. 2022.

review2022
3

Burnichon N, Mazzella JM, Billharz C. The Genetics of Paraganglioma and Pheochromocytoma Syndromes. Endocrinol Metab Clin North Am. 2017.

review2017
4

Bayley JP, van der Tuin K, Hannema G. Clinical Presentation and Genetics of MAX-associated Pheochromocytoma/Paraganglioma. Fam Cancer. 2020.

other2020

Medication Comparisons

Compare medications used to treat Pheochromocytoma Paraganglioma Syndrome 7 C5193116. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy